이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

명상자의 인지 기능과 정서 조절 (CALM)

2026년 11월 5일 업데이트: Balachundhar Subramaniam

명상자들의 인지 기능과 정서 조절

This is a prospective cohort study with 52 meditators and 52 controls. These groups will be contacted at a singular timepoint, during which they will take surveys and cognitive tests, which will be used to assess cognitive and emotional outcomes. The meditator group will be recruited from a pool of healthy individuals who have learned meditation practices such as those taught by the Isha Foundation (e.g., Shambhavi Mahamudra Kriya, Shoonya, Samyama breath-watching, etc.) Meditation-naïve individuals will be recruited into the control group.

연구 개요

상세 설명

This is a prospective cohort study with 52 meditators and 52 controls. These groups will be contacted at a singular timepoint, during which they will take surveys and cognitive tests, which will be used to assess cognitive and emotional outcomes. The meditator group will be recruited from a pool of healthy individuals who have learned meditation practices such as those taught by the Isha Foundation (e.g., Shambhavi Mahamudra Kriya, Shoonya, Samyama breath-watching, etc.) Meditation-naïve individuals will be recruited into the control group. Despite allocation to 2 separate cohorts, both groups will be subjected to identical questionnaires and tasks at the singular timepoint. Further, none of the above practices are being taught by the study team. Rather, the investigators are only looking to study the effects of the aforementioned practices on participants through validated survey questionnaires and cognitive tasks.

Study Procedure: Following e-consent and enrollment into the study, participants are asked to complete electronic surveys and cognitive tasks. These will either be completed virtually on the participants' own device or on a BIDMC-approved device brought to the participant by the study team. (Further details on the remote administration of surveys and cognitive tasks explained below)

Questionnaire: The following questionnaires are incorporated into the study and will be administered to the study participants at a single timepoint.

Demographic, medical history, past meditation experience, and habits: Collects demographic details (age, ethnicity, gender, education/employment, marital status, number of children, country of residence), meditation exposure and duration of practice, past cognitive training, alcohol use, and smoking.

Cognitive Emotional Regulation Questionnaire (CERQ): This survey aims to collect information on a person's thoughts after having experienced a negative event.

Positive And Negative Affect Schedule (PANAS): Comprises two mood scales measuring positive affect and negative affect. Participants respond to a 20-item test using a 5-point scale that ranges from very slightly or not at all (1) to extremely (5). Scores can range from 10-50 for both the Positive and Negative affect with lower scores representing lower levels of affect and higher scores representing higher levels of affect.

Four-Item Patient Health Questionnaires (PHQ-4) for Anxiety & Depression: Assesses anxiety and depression. Scores range from 0-12 with subscales for anxiety (items 1-2) and depression (items 3-4); scores greater than 3 on each subscale are considered positive.

Perceived Stress Scale (PSS): 10-question validated instrument that assesses stress. Participants are asked to rate on a scale of 0 (never) to 4 (very often) how often they agree with various statements. Items from each of the 10 questions are then summed to create a total perceived stress score. Please see the survey details in the attached "Study Questionnaire" attachment.

Cognitive Tasks: Participants will be asked to complete a set of cognitive tasks to assess executive function, attention, memory, and affect regulation. The tasks would require participants to respond in a specific manner to certain stimuli based on the instructions appearing on the screen. The tasks may also contain images with positive or negative emotional content. Some examples of the tasks that may be used in this study are provided below.

Multi-Source Interference Task (MSIT): Participants are presented with a sequence of three numbers in each trial and are asked to identify and press the key corresponding to the number that is not repeated. In "congruent" trials, the target number appears in the spot corresponding to its value and is flanked by zeros (e.g., "0 2 0"). In "incongruent" trials, the target number is in a spot that does not correspond to its value and is flanked by a non-zero digit (e.g., "3 3 2"). Images with positive, negative, or neutral emotional content are presented simultaneously with the number sequences to test emotional regulation.

N-back Task: Participants are presented with a sequence of letters. Participants are given two keys they can respond with. They are asked to press one key if the current letter is the same as the letter that was presented n letters back, and press the other key if the current letter does not match the letter that was presented n letters back.

These cognitive tasks will be either administered remotely through a secure online cognitive task hosting platform such as Pavlovia (pavlovia.org). Participants will be provided the link to the task on the online platform, and will only be asked to enter their de-identified study ID (e.g., CALM01, CALM02). This link will be unique to the study and will be generated and sent to participants once they enroll in the study.

연구 유형

관찰

등록 (추정된)

104

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • Massachusetts
      • Boston, Massachusetts, 미국, 02215
        • 모병
        • BIDMC

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

Subjects will not be recruited based on race, ethnicity, or gender. However, it is not clear whether the final study sample will contain a representative spread of the racial and gender makeup. There is no reason to exclude pregnant women from this protocol.

설명

Inclusion Criteria:

  • Participants must be able to read and understand English.
  • Meditators: Participants must regularly practice meditation (4 or more times per week).
  • Controls: Participants must not regularly practice meditation (4 or more times per week)

Exclusion Criteria:

  • Below the age of 18.
  • Participants not living in the US.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: CROSS_SECTIONAL

코호트 및 개입

그룹/코호트
Meditators

Participants who regularly practice meditation (4 or more times per week)

Controls

Participants who do not regularly practice meditation (4 or more times per week)

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Multi-Source Interference Task (MSIT)
기간: within one week of consent

Participants are presented with a sequence of three numbers in each trial and are asked to identify and press the key corresponding to the number that is not repeated. In "congruent" trials, the target number appears in the spot corresponding to its value and is flanked by zeros (e.g., "0 2 0"). In "incongruent" trials, the target number is in a spot that does not correspond to its value and is flanked by a non-zero digit (e.g., "3 3 2"). Images with positive, negative, or neutral emotional content are presented simultaneously with the number sequences to test emotional regulation.

within one week of consent
N-back Task
기간: within one week of consent

Participants are presented with a sequence of letters. Participants are given two keys they can respond with. They are asked to press one key if the current letter is the same as the letter that was presented n letters back, and press the other key if the current letter does not match the letter that was presented n letters back.

within one week of consent

2차 결과 측정

결과 측정
측정값 설명
기간
Cognitive Emotional Regulation Questionnaire (CERQ)
기간: within one week of consent

This survey aims to collect information on a person's thoughts after having experienced a negative event. Comprised of 36-items, with scores from 1 (never) to 5 (always), total subscale scores range from 4 to 20. Higher subscale scores indicate increased frequency of use for the specified regulation strategy.

within one week of consent
Positive And Negative Affect Schedule (PANAS)
기간: within one week of consent

Comprises two mood scales measuring positive affect and negative affect. Participants respond to a 20-item test using a 5-point scale that ranges from very slightly or not at all (1) to extremely (5). Total sScores can range from 10-50 for both the Positive and Negative affect with lower scores representing lower levels of affect and higher scores representing higher levels of affect.

within one week of consent
Four-Item Patient Health Questionnaires (PHQ-4) for Anxiety & Depression
기간: within one week of consent

Total scores range from 0-12 with subscales for anxiety (items 1-2) and depression (items 3-4); scores greater than 3 on each subscale are considered positive. Higher scores indicate increased anxiety/depression symptoms.

within one week of consent
Perceived Stress Scale (PSS)
기간: within one week of consent

10-question validated instrument that assesses stress. Participants are asked to rate on a scale of 0 (never) to 4 (very often) how often they agree with various statements. Items from each of the 10 questions are then summed to create a total perceived stress score, with a minimum score of 0 and maximum score of 40. Higher scores indicate a higher level or perceived stress.

within one week of consent

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2024년 2월 9일

기본 완료 (추정된)

2027년 12월 31일

연구 완료 (추정된)

2027년 12월 31일

연구 등록 날짜

최초 제출

2026년 1월 13일

QC 기준을 충족하는 최초 제출

2026년 4월 16일

처음 게시됨 (실제)

2026년 4월 23일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 10일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 5일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

키워드

기타 연구 ID 번호

  • 2023P000588

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다